Description

BSE announces listing of 6000 Commercial Papers of Manappuram Finance Limited worth Rs. 5 lakhs each, issued on private placement basis with redemption date of February 13, 2026.

Summary

BSE has listed and admitted new Commercial Paper securities of Manappuram Finance Limited on the Debt segment effective November 17, 2025. The securities were issued on private placement basis with a total quantity of 6000 units at face value of Rs. 5,00,000 each. The instruments carry CARE A1+ and CRISIL A1+ credit ratings and will be traded exclusively in dematerialized form.

Key Points

  • Total quantity: 6000 Commercial Papers of Rs. 5,00,000 face value each
  • Scrip Code: 730578, Scrip ID: MFL141125
  • ISIN Number: INE522D14OW7
  • Issue Price: Rs. 4,91,243 per unit
  • Credit Rating: CARE A1+ and CRISIL A1+
  • Market Lot: 1 unit
  • Trading permitted only in dematerialized form
  • Standard denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise
  • Issuing and Paying Agent: AXIS BANK

Regulatory Changes

No regulatory changes introduced. This is a standard listing notification.

Compliance Requirements

Trading members are informed that:

  • Securities must be traded only in dematerialized form under ISIN INE522D14OW7
  • Trading shall take place in standard denomination of Rs. 5 lakhs and multiples
  • Tick size for securities is 1 paise
  • Contact debt department at 22728352/8597/8995/5753/8915 for clarifications

Important Dates

  • Allotment Date: November 14, 2025
  • Listing Date: November 17, 2025
  • Redemption Date: February 13, 2026

Impact Assessment

This is a routine listing announcement with minimal market impact. The listing provides short-term debt market participants access to investment-grade commercial paper of Manappuram Finance Limited with a 91-day tenor. The high credit ratings (A1+ from both CARE and CRISIL) indicate strong creditworthiness. No operational changes or compliance burden for general market participants.

Impact Justification

Routine commercial paper listing announcement with no regulatory changes or compliance requirements for market participants beyond informational awareness